STOCK TITAN

Accenture Plc Ireland Financials

ACN
Trailing 12 months to May 31, 2026
Revenue $73.1B +6.7% YoY
Net Income $7.8B -2.0% YoY
EPS (Diluted) $12.52 -0.3% YoY
Free Cash Flow $12.6B +22.8% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Currency USD FYE August

Accenture Plc Ireland (ACN) reported $73.1B in revenue over the twelve months to May 31, 2026, up 6.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ACN FY2025

Accenture operates as an asset-light cash engine, holding steady margins while requiring very little reinvestment to grow.

In FY2025, free cash flow reached $10.9B while capex was only $600M, so almost all operating cash remained available after maintenance spending. Because operating margin stayed near 15.0% rather than jumping, the cash improvement looks more like better cash conversion than a fundamental change in pricing or cost structure.

The business has kept gross margin near 32.0% and operating margin near 15.0% across several years, which points to a delivery model whose economics stay stable as volume rises. That is different from a company needing big factories or one-time cost cuts to defend profitability.

FY2025 added $5.0B of long-term debt, but cash also climbed to $11.5B, leaving the company with a net cash cushion rather than a balance sheet dependent on lenders. Goodwill also rose to $22.5B, and ROA eased to 11.7%, suggesting acquisitions have expanded the asset base faster than they have improved efficiency.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 73 / 100
Financial Health Score 73/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Accenture Plc Ireland's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
85

Accenture Plc Ireland has an operating margin of 14.7%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 85/100, reflecting efficient cost management and pricing power. This is down from 14.8% the prior year.

Growth
47

Accenture Plc Ireland's revenue grew 7.4% year-over-year to $69.7B, a solid pace of expansion. This earns a growth score of 47/100.

Leverage
94

Accenture Plc Ireland carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
38

Accenture Plc Ireland's current ratio of 1.42 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
78

Accenture Plc Ireland converts 15.6% of revenue into free cash flow ($10.9B). This strong cash generation earns a score of 78/100.

Returns
93

Accenture Plc Ireland earns a strong 24.6% return on equity (ROE), meaning it generates $25 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 93/100. This is down from 25.7% the prior year.

Altman Z-Score Safe
4.20

Accenture Plc Ireland scores 4.20, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Accenture Plc Ireland passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.49x

For every $1 of reported earnings, Accenture Plc Ireland generates $1.49 in operating cash flow ($11.5B OCF vs $7.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
44.74x

Accenture Plc Ireland earns $44.74 in operating income for every $1 of interest expense ($10.2B vs $228.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$69.7B
YoY+7.4%
5Y CAGR+9.5%
10Y CAGR+7.8%

Accenture Plc Ireland generated $69.7B in revenue in fiscal year 2025. This represents an increase of 7.4% from the prior year.

EBITDA
$11.6B
YoY+5.0%
5Y CAGR+9.0%
10Y CAGR+8.6%

Accenture Plc Ireland's EBITDA was $11.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.0% from the prior year.

Net Income
$7.7B
YoY+5.7%
5Y CAGR+8.5%
10Y CAGR+9.7%

Accenture Plc Ireland reported $7.7B in net income in fiscal year 2025. This represents an increase of 5.7% from the prior year.

EPS (Diluted)
$12.15
YoY+6.2%
5Y CAGR+9.0%
10Y CAGR+9.8%

Accenture Plc Ireland earned $12.15 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$10.9B
YoY+26.2%
5Y CAGR+7.4%
10Y CAGR+11.1%

Accenture Plc Ireland generated $10.9B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 26.2% from the prior year.

Cash & Debt
$11.5B
YoY+129.4%
5Y CAGR+6.4%
10Y CAGR+10.2%

Accenture Plc Ireland held $11.5B in cash against $5.0B in long-term debt as of fiscal year 2025.

Dividends Per Share
$5.92
YoY+14.7%
5Y CAGR+13.1%
10Y CAGR+11.2%

Accenture Plc Ireland paid $5.92 per share in dividends in fiscal year 2025. This represents an increase of 14.7% from the prior year.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
31.9%
YoY-0.7pp
5Y CAGR+0.4pp
10Y CAGR+2.1pp

Accenture Plc Ireland's gross margin was 31.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the prior year.

Operating Margin
14.7%
YoY-0.1pp
5Y CAGR0.0pp
10Y CAGR+1.2pp

Accenture Plc Ireland's operating margin was 14.7% in fiscal year 2025, reflecting core business profitability. This is down 0.1 percentage points from the prior year.

Net Margin
11.0%
YoY-0.2pp
5Y CAGR-0.5pp
10Y CAGR+1.7pp

Accenture Plc Ireland's net profit margin was 11.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.2 percentage points from the prior year.

Return on Equity
24.6%
YoY-1.1pp
5Y CAGR-5.4pp
10Y CAGR-25.2pp

Accenture Plc Ireland's ROE was 24.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending
$817.3M
YoY-29.0%
5Y CAGR-1.3%
10Y CAGR+2.7%

Accenture Plc Ireland invested $817.3M in research and development in fiscal year 2025. This represents a decrease of 29.0% from the prior year.

Share Buybacks
$4.6B
YoY+2.1%
5Y CAGR+9.6%
10Y CAGR+6.5%

Accenture Plc Ireland spent $4.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 2.1% from the prior year.

Capital Expenditures
$600.0M
YoY+16.2%
5Y CAGR0.0%
10Y CAGR+4.3%

Accenture Plc Ireland invested $600.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.2% from the prior year.

ACN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACN quarterly income statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Revenue$18.7B+3.7%$18.0B-3.7%$18.7B+6.5%$17.6B-0.7%$17.7B+6.4%$16.7B-5.8%$17.7B+7.8%$16.4B
Cost of Revenue$12.6B0.0%$12.6B+0.3%$12.5B+4.7%$12.0B+0.7%$11.9B+1.9%$11.7B-1.5%$11.9B+7.2%$11.1B
Gross Profit$6.1B+12.4%$5.5B-11.9%$6.2B+10.4%$5.6B-3.7%$5.8B+17.1%$5.0B-14.6%$5.8B+9.1%$5.3B
SG&A Expenses$1.1B-5.7%$1.2B+6.7%$1.1BN/A$1.1B+2.6%$1.1B-0.9%$1.1BN/A
Operating Income$3.2B+27.3%$2.5B-13.2%$2.9B+40.2%$2.0B-31.3%$3.0B+32.9%$2.2B-23.9%$2.9B+25.3%$2.4B
Interest Expense$70.6M+11.1%$63.6M-2.8%$65.4MN/A$67.6M+4.5%$64.7M+115.3%$30.0MN/A
Income Tax$761.9M+27.6%$597.3M-17.7%$725.8MN/A$707.2M+51.6%$466.3M-27.0%$639.1MN/A
Net Income$2.3B+28.1%$1.8B-17.5%$2.2B+56.4%$1.4B-35.7%$2.2B+22.9%$1.8B-21.5%$2.3B+35.3%$1.7B
EPS (Diluted)$3.80+29.7%$2.93-17.2%$3.54+57.3%$2.25-35.5%$3.49+23.8%$2.82-21.4%$3.59+35.0%$2.66

Not reported in any period shown, so not listed: R&D Expenses.

ACN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACN quarterly balance sheet
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Total Assets$68.8B+2.6%$67.1B+3.7%$64.7B-1.1%$65.4B+3.2%$63.4B+5.8%$59.9B0.0%$59.9B+7.0%$55.9B
Current Assets$28.9B+3.3%$28.0B-0.2%$28.1B-2.9%$28.9B+5.4%$27.4B+8.3%$25.3B+0.4%$25.2B+20.8%$20.9B
Cash & Equivalents$10.2B+8.2%$9.4B-2.6%$9.6B-15.9%$11.5B+19.2%$9.6B+13.4%$8.5B+2.2%$8.3B+66.0%$5.0B
Accounts Receivable$14.0B+1.7%$13.8B-1.2%$13.9B+6.6%$13.1B-0.4%$13.1B+5.5%$12.4B-1.2%$12.6B+6.0%$11.9B
Goodwill$25.3B+3.0%$24.6B+8.7%$22.6B+0.4%$22.5B+3.4%$21.8B+4.1%$20.9B+0.4%$20.9B-1.2%$21.1B
Total Liabilities$36.9B+3.0%$35.9B+6.0%$33.8B-1.1%$34.2B+4.2%$32.8B+7.1%$30.6B-0.2%$30.7B+11.0%$27.6B
Current Liabilities$21.6B+3.1%$21.0B+5.3%$19.9B-2.2%$20.4B+8.4%$18.8B+9.6%$17.1B-0.3%$17.2B-9.4%$19.0B
Long-Term Debt$5.0B0.0%$5.0B0.0%$5.0B-0.1%$5.0B0.0%$5.0B-0.1%$5.0B+0.1%$5.0B+6309.2%$78.6M
Total Equity$31.9B+2.2%$31.2B+1.1%$30.9B-1.1%$31.2B+2.1%$30.6B+4.5%$29.2B+0.2%$29.2B+3.2%$28.3B
Retained Earnings$24.0B+5.4%$22.8B+3.0%$22.1B+5.4%$21.0B-20.5%$26.5B+4.9%$25.2B+3.3%$24.4B+5.7%$23.1B

Not reported in any period shown, so not listed: Inventory.

ACN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACN quarterly cash flow statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Operating Cash Flow$3.8B-0.8%$3.8B+129.4%$1.7B-57.5%$3.9B+6.2%$3.7B+29.1%$2.9B+179.1%$1.0B-69.8%$3.4B
Capital Expenditures$186.2M+24.4%$149.7M-4.4%$156.6M+45.1%$107.9M-36.2%$169.1M-1.0%$170.8M+12.2%$152.2M-28.8%$213.6M
Free Cash Flow$3.6B-1.9%$3.7B+143.3%$1.5B-60.4%$3.8B+8.3%$3.5B+31.0%$2.7B+208.2%$870.3M-72.6%$3.2B
Investing Cash Flow-$1.2B+30.7%-$1.7B-244.8%-$504.9M+34.5%-$771.3M-69.3%-$455.6M-11.9%-$407.3M-5.6%-$385.5M+75.1%-$1.5B
Financing Cash Flow-$1.8B+26.8%-$2.4B+17.1%-$2.9B-128.3%-$1.3B+42.6%-$2.2B-0.7%-$2.2B-180.1%$2.8B+213.3%-$2.4B
Share Buybacks$1.2B-29.5%$1.7B-28.0%$2.3B+391.8%$473.9M-73.7%$1.8B+24.3%$1.4B+61.2%$898.3M+42.9%$628.4M

Not reported in any period shown, so not listed: Dividends Paid.

ACN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ACN quarterly financial ratios
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Gross Margin32.8%+2.5pp30.3%-2.8pp33.1%+1.2pp31.9%-1.0pp32.9%+3.0pp29.9%-3.1pp32.9%+0.4pp32.5%
Operating Margin17.0%+3.1pp13.8%-1.5pp15.3%+3.7pp11.7%-5.2pp16.8%+3.4pp13.5%-3.2pp16.7%+2.3pp14.3%
Net Margin12.5%+2.4pp10.1%-1.7pp11.8%+3.8pp8.0%-4.4pp12.4%+1.7pp10.7%-2.1pp12.9%+2.6pp10.3%
Return on Equity7.3%+1.5pp5.9%-1.3pp7.2%+2.6pp4.5%-2.7pp7.2%+1.1pp6.1%-1.7pp7.8%+1.9pp5.9%
Return on Assets3.4%+0.7pp2.7%-0.7pp3.4%+1.3pp2.2%-1.3pp3.5%+0.5pp3.0%-0.8pp3.8%+0.8pp3.0%
Current Ratio1.340.0x1.34-0.1x1.410.0x1.420.0x1.460.0x1.480.0x1.47+0.4x1.10
Debt-to-Equity0.160.0x0.160.0x0.160.0x0.160.0x0.160.0x0.170.0x0.17+0.2x0.00
FCF Margin19.2%-1.1pp20.3%+12.3pp8.0%-13.6pp21.6%+1.8pp19.8%+3.7pp16.1%+11.2pp4.9%-14.4pp19.4%

Similar Companies

Frequently Asked Questions

What is Accenture Plc Ireland's annual revenue?

Accenture Plc Ireland (ACN) reported $69.7B in total revenue for fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Accenture Plc Ireland's revenue growing?

Accenture Plc Ireland (ACN) revenue grew by 7.4% year-over-year, from $64.9B to $69.7B in fiscal year 2025.

Is Accenture Plc Ireland profitable?

Yes, Accenture Plc Ireland (ACN) reported a net income of $7.7B in fiscal year 2025, with a net profit margin of 11.0%.

Accenture Plc Ireland (ACN) reported diluted earnings per share of $12.15 for fiscal year 2025. This represents a 6.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Accenture Plc Ireland (ACN) had EBITDA of $11.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Accenture Plc Ireland (ACN) had $11.5B in cash and equivalents against $5.0B in long-term debt.

Accenture Plc Ireland (ACN) had a gross margin of 31.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Accenture Plc Ireland (ACN) had an operating margin of 14.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Accenture Plc Ireland (ACN) had a net profit margin of 11.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Accenture Plc Ireland (ACN) paid $5.92 per share in dividends during fiscal year 2025.

Accenture Plc Ireland (ACN) has a return on equity of 24.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Accenture Plc Ireland (ACN) generated $10.9B in free cash flow during fiscal year 2025. This represents a 26.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Accenture Plc Ireland (ACN) generated $11.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Accenture Plc Ireland (ACN) had $65.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Accenture Plc Ireland (ACN) invested $600.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Accenture Plc Ireland (ACN) invested $817.3M in research and development during fiscal year 2025.

Yes, Accenture Plc Ireland (ACN) spent $4.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Accenture Plc Ireland (ACN) had a current ratio of 1.42 as of fiscal year 2025, which is considered adequate.

Accenture Plc Ireland (ACN) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Accenture Plc Ireland (ACN) had a return on assets of 11.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Accenture Plc Ireland (ACN) has an Altman Z-Score of 4.20, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Accenture Plc Ireland (ACN) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Accenture Plc Ireland (ACN) has an earnings quality ratio of 1.49x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Accenture Plc Ireland (ACN) has an interest coverage ratio of 44.74x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Accenture Plc Ireland (ACN) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top